Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL776390 | 0.89 | ALDH1A1 (0.40) | ALDH1A1 | |
| SCHEMBL25283330 | 0.89 | — | — | |
| SCHEMBL28992479 | 0.85 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL25239066 | 0.85 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL25282841 | 0.84 | — | — | |
| SCHEMBL2306829 | 0.84 | ALDH1A1 (0.43) | ALDH1A1 | |
| SCHEMBL25285348 | 0.83 | HTT (0.31) | — | |
| SCHEMBL28841924 | 0.83 | HTT (0.31) | — | |
| SCHEMBL6754622 | 0.81 | — | — | |
| SCHEMBL25240582 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250174720-A1 | ELECTROLYTE, ELECTROCHEMICAL DEVICE, LITHIUM ION SECONDARY BATTERY, AND MODULE | DAIKIN INDUSTRIES, LTD. (JP) | 2025-05-29 | — | — | US | disclosed |
| EP-3709426-B1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ENERGY DEVICE USING SAME | MITSUBISHI CHEM CORP (JP) | 2025-02-26 | — | — | EP | disclosed |
| US-12100809-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-24 | — | — | US | disclosed |
| CN-111919326-B | Electrolyte, electrochemical device, lithium ion secondary battery, assembly, and compound | 大金工业株式会社 | 2024-06-11 | — | — | CN | disclosed |
| CN-118026845-A | Fluoroacetate compound | 大金工业株式会社 | 2024-05-14 | — | — | CN | disclosed |
| US-20240154170-A1 | NONAQUEOUS ELECTROLYTE, NONAQUEOUS ELECTROLYTE SECONDARY BATTERY, AND ENERGY DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-05-09 | — | — | US | disclosed |
| CN-111937215-B | Electrolyte, electrochemical device, lithium ion secondary battery, and assembly | 大金工业株式会社 | 2024-04-19 | — | — | CN | disclosed |
| CN-111108642-B | Nonaqueous electrolyte, nonaqueous electrolyte secondary battery, and energy device | 三菱化学株式会社 | 2024-04-02 | — | — | CN | disclosed |
| CN-117790904-A | Nonaqueous electrolyte, nonaqueous electrolyte secondary battery, and energy device | 三菱化学株式会社 | 2024-03-29 | — | — | CN | disclosed |
| CN-112042036-B | Electrolyte, electrochemical device, lithium ion secondary battery, and assembly | 大金工业株式会社 | 2024-03-05 | — | — | CN | disclosed |
| US-8263606-B2 | Spiro-oxindole compounds and their use as therapeutic agents | XENON PHARMACEUTICALS INC. (CA) | 2012-09-11 | — | — | US | disclosed |
| US-20120177988-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-07-12 | — | — | US | disclosed |
| US-20120070731-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-03-22 | — | — | US | disclosed |
| EP-2350090-A2 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | Xenon Pharmaceuticals Inc. (CA) | 2011-08-03 | — | — | EP | disclosed |
| US-20100137299-A1 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS INC. (CA) | 2010-06-03 | — | — | US | disclosed |
| WO-2010045251-A2 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS, INC. (CA) | 2010-04-22 | — | — | WO | disclosed |
| US-20090325065-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2009-12-31 | — | — | US | disclosed |
| EP-2012386-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2009-01-07 | — | — | EP | disclosed |
| EP-0134246-B1 | PROSTACYCLINES AND PROCESS FOR THEIR PREPARATION | TEIJIN LIMITED (JP) | 1989-08-23 | — | — | EP | disclosed |
| EP-0134246-A1 | PROSTACYCLINES AND PROCESS FOR THEIR PREPARATION | TEIJIN LIMITED (JP) | 1985-03-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250174720-A1 | ELECTROLYTE, ELECTROCHEMICAL DEVICE, LITHIUM ION SECONDARY BATTERY, AND MODULE | HCN2, HCN1, HCN3 | ALDH1A1 955/4885 |
| US-20100137299-A1 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | TRPV3, TRPV1, TRPC3 | ALDH1A1 1020/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.